Xiaolu Yu
Impact in
- Geriatrics and Gerontology top 10%
-
- Immune cells in cancer
- Immunotherapy and Immune Responses
Papers in
- Oncology 10
- Cancer Immunotherapy and Biomarkers 7
- Co-authors
- Li Liu (3 shared papers)Yakun Wan (4 shared papers)Xingyao Li (3 shared papers)Hailun Gu (3 shared papers)Yongzhuo Huang (3 shared papers)Lifeng Ding (2 shared papers)Binfan Chen (2 shared papers)Likun Gong (9 shared papers)
- Journals
- Acta Pharmacologica Sinica (3 papers)Frontiers in Immunology (2 papers)Journal of Clinical Oncology (2 papers)Nutrients (1 paper)Scientific Reports (1 paper)
- Partner nations
- ChinaUnited StatesSwitzerland
In The Last Decade
Xiaolu Yu
29 papers receiving 639 citations
Peers
Comparison fields: 5 of 81
- Geriatrics and Gerontology 33
- Immunology 159
- Oncology 192
- Cancer Research 92
- Rheumatology 86
Countries citing papers authored by Xiaolu Yu
This map shows the geographic impact of Xiaolu Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolu Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolu Yu more than expected).
Fields of papers citing papers by Xiaolu Yu
This network shows the impact of papers produced by Xiaolu Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolu Yu. The network helps show where Xiaolu Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaolu Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 105 | |
| 2 | 2018 | 63 | |
| 3 | 2017 | 54 | |
| 4 | 2016 | 47 | |
| 5 | 2017 | 44 | |
| 6 | 2019 | 36 | |
| 7 | 2022 | 35 | |
| 8 | 2024 | 33 | |
| 9 | 2019 | 30 | |
| 10 | 2020 | 26 | |
| 11 | 2022 | 26 | |
| 12 | 2016 | 24 | |
| 13 | 2015 | 24 | |
| 14 | 2022 | 17 | |
| 15 | 2022 | 14 | |
| 16 | 2018 | 9 | |
| 17 | 2014 | 9 | |
| 18 | 2022 | 8 | |
| 19 | 2023 | 6 | |
| 20 | 2022 | 6 |
About Xiaolu Yu
Xiaolu Yu is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Immunology and Rheumatology, having authored 29 papers that have together received 643 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (7 papers), Lung Cancer Treatments and Mutations (5 papers), Immunotherapy and Immune Responses (4 papers), Immune cells in cancer (3 papers), Osteoarthritis Treatment and Mechanisms (3 papers), Lung Cancer Diagnosis and Treatment (3 papers), Endoplasmic Reticulum Stress and Disease (2 papers) and Immune Cell Function and Interaction (2 papers). The work is most often cited by research in Geriatrics and Gerontology (33 citations), Immunology (159 citations), Oncology (192 citations), Cancer Research (92 citations) and Rheumatology (86 citations). Xiaolu Yu has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include Li Liu, Yakun Wan, Xingyao Li, Hailun Gu, Yongzhuo Huang, Lifeng Ding, Binfan Chen, Likun Gong, Yonghui Wang and Bing Wang. Their work appears in journals such as Acta Pharmacologica Sinica, Frontiers in Immunology, Journal of Clinical Oncology, Nutrients and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.